Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma

Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Takeshi Harada, Shingen Nakamura, Ryota Amachi, Hirofumi Tenshin, Masami Iwasa, Shiro Fujii, Kumiko Kagawa, Hirokazu Miki, Kiyoe Kurahashi, Sumiko Yoshida, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto, Masahiro Abe

Research output: Contribution to journalLetterpeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)581-585
Number of pages5
JournalBritish Journal of Haematology
Volume180
Issue number4
DOIs
Publication statusPublished - Feb 1 2018
Externally publishedYes

Keywords

  • Pim-2
  • bone destruction
  • myeloma
  • osteoclastogenesis
  • receptor activator of NF-κB ligand

ASJC Scopus subject areas

  • Hematology

Cite this